The Healthcare Technology Report.

Tempus AI is buying Personalis, the cancer diagnostics company behind a test Tempus already markets, in a deal valued at $1.5 billion. The acquisition would give Tempus control of NeXT Personal, a molecular residual disease test that looks for small traces of tumor DNA in the blood. Doctors can use the test to monitor how a patient responds to treatment, detect remaining canc...

The Bezos Earth Fund is committing $100 million to turn asphalt lots, vacant properties, a former highway interchange, and an abandoned industrial quarry into parks and green spaces across eight U.S. cities.

The new round of funding will support projects in Allentown, Atlanta, Cleveland, Indianapolis, Little Rock, Los Angeles, Salt Lake City, and Sioux Falls. Plans ran...

Net Health has appointed healthcare technology executive B.J. Boyle as Chief Product Officer, placing him in charge of product strategy for a specialty care platform used by more than 34,000 healthcare organizations.

Boyle joins Net Health from MacroHealth, where he served as chief product officer. He previously spent nine years at PointClickCare, most recently as chie...

Headspace has established referral partnerships with Charlie Health, Cortica, Prosper Health, and Equip, giving members and their families more direct pathways to specialty mental healthcare.

The partnerships cover autism and other neurodevelopmental conditions, eating disorders, substance use, and mental health needs requiring more intensive support than weekly therap...

Sanofi will reorganize its Executive Committee on September 1, expanding the responsibilities of its finance function and consolidating the pharmaceutical company’s senior leadership team.

Finance will assume responsibility for enterprise business services, Global Partnering, Business Development, and mergers and acquisitions. François Roger will continue leading the f...